Consolidation has little impact on the top positions
This article was originally published in Clinica
Clinica's analysis of the latest available company figures shows little change in ranking by revenue in the last five years, despite much consolidation in the industry. Our predictions for the top ten companies of 1998 show two new entries.
You may also be interested in...
The UK’s Artios has linked up with Merck KGaA in a potentially multi-billion dollar deal to collaborate on discovering and developing up to eight oncology drug targets associated with DNA damage response processes, and is also progressing its own lead compounds through its pipeline.
The UK’s rapid authorization of the Pfizer/BioNTech COVID-19 vaccine has sparked a public debate over regulatory processes at some of the world’s key regulatory bodies.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.